<?xml version="1.0" encoding="UTF-8"?>

<!--L
  Copyright Oracle Inc

  Distributed under the OSI-approved BSD 3-Clause License.
  See http://ncip.github.com/cadsr-cgmdr-nci-uk/LICENSE.txt for details.
L-->

<cgMDR:Enumerated_Conceptual_Domain xmlns:cgMDR="http://www.cancergrid.org/schema/cgMDR" item_registration_authority_identifier="US-NCICB-CACORE" data_identifier="D1E75680" version="1">
    <cgMDR:administered_item_administration_record>
        <cgMDR:administrative_status>noPendingChanges</cgMDR:administrative_status>
        <cgMDR:creation_date>2007-07-17</cgMDR:creation_date>
        <cgMDR:effective_date>2007-07-17</cgMDR:effective_date>
        <cgMDR:explanatory_comment>Transformed from NCICB caDSR</cgMDR:explanatory_comment>
        <cgMDR:last_change_date>2007-07-17</cgMDR:last_change_date>
        <cgMDR:registration_status>Standard</cgMDR:registration_status>
    </cgMDR:administered_item_administration_record>
    <cgMDR:administered_by>US-NCICB-CTEP-STEWARD</cgMDR:administered_by>
    <cgMDR:registered_by>US-NCICB-CACORE-REGISTRAR</cgMDR:registered_by>
    <cgMDR:submitted_by>US-NCICB-CTEP-SUMBMITTER</cgMDR:submitted_by>
    <cgMDR:having>
        <cgMDR:context_identifier>US-NCICB-CTEP-1</cgMDR:context_identifier>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>US</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>Adverse Events</cgMDR:name>
            <cgMDR:definition_text/>
            <cgMDR:preferred_designation>true</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
        <cgMDR:containing>
            <cgMDR:language_section_language_identifier>
                <cgMDR:country_identifier>US</cgMDR:country_identifier>
                <cgMDR:language_identifier>eng</cgMDR:language_identifier>
            </cgMDR:language_section_language_identifier>
            <cgMDR:name>AE</cgMDR:name>
            <cgMDR:definition_text/>
            <cgMDR:preferred_designation>false</cgMDR:preferred_designation>
            <cgMDR:definition_source_reference/>
        </cgMDR:containing>
    </cgMDR:having>
    <cgMDR:dimensionality/>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >NONE</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75682</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >DEATH</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75691</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >5 - 10% inter-limb discrepancy in volume or circumference at point of
                  greatest visible difference; swelling or obscuration of anatomic architecture on
                  close inspection; pitting edema</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75700</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >&gt;10 - 30% inter-limb discrepancy in volume or circumference at
                  point of greatest visible difference; readily apparent obscuration of anatomic
                  architecture; obliteration of skin folds; readily apparent deviation from normal
                  anatomic contour</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75709</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >Progression to malignancy (i.e., lymphangiosarcoma); ampuation
                  indicated; disabling</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75718</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
    <cgMDR:Value_Meaning>
        <cgMDR:value_meaning_begin_date >2007-07-17</cgMDR:value_meaning_begin_date>
        <cgMDR:value_meaning_description >&gt;30% inter-limb discrepancy in volume; lymphorrhea; gross
                  deviation from normal anatomic contour; interfering with ADL</cgMDR:value_meaning_description>
        <cgMDR:value_meaning_identifier >D1E75728</cgMDR:value_meaning_identifier>
    </cgMDR:Value_Meaning>
</cgMDR:Enumerated_Conceptual_Domain>